MORGAN STANLEY - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$24,544,019
-28.8%
1,995,448
-6.9%
0.00%
-33.3%
Q2 2023$34,459,144
-6.8%
2,144,315
+0.9%
0.00%
-25.0%
Q1 2023$36,982,672
+119.8%
2,124,220
+16.7%
0.00%
+100.0%
Q4 2022$16,823,795
+26.5%
1,820,757
+17.9%
0.00%0.0%
Q3 2022$13,299,000
+23.8%
1,544,640
+17.2%
0.00%
+100.0%
Q2 2022$10,739,000
+9.6%
1,317,608
+63.4%
0.00%0.0%
Q1 2022$9,798,000
-66.7%
806,471
-6.4%
0.00%
-75.0%
Q4 2021$29,412,000
-35.9%
862,030
-9.4%
0.00%
-33.3%
Q3 2021$45,889,000
+15.1%
951,297
+7.8%
0.01%
+20.0%
Q2 2021$39,876,000
-2.3%
882,792
+4.3%
0.01%
-16.7%
Q1 2021$40,825,000
+31.4%
846,443
+46.7%
0.01%
+20.0%
Q4 2020$31,058,000
+20.4%
576,833
-17.5%
0.01%0.0%
Q3 2020$25,785,000
+85.2%
698,988
+55.5%
0.01%
+66.7%
Q2 2020$13,926,000
-1.7%
449,518
-12.4%
0.00%
-25.0%
Q1 2020$14,171,000
-21.0%
513,310
-16.3%
0.00%0.0%
Q4 2019$17,942,000
+44.5%
613,380
-5.5%
0.00%
+33.3%
Q3 2019$12,414,000
-5.6%
649,243
+8.3%
0.00%
-25.0%
Q2 2019$13,153,000
+2.7%
599,506
-4.3%
0.00%0.0%
Q1 2019$12,812,000
+57.4%
626,261
-3.0%
0.00%
+100.0%
Q4 2018$8,141,000
-49.8%
645,631
-38.9%
0.00%
-50.0%
Q3 2018$16,225,000
+855.5%
1,056,917
+716.1%
0.00%
Q2 2018$1,698,000
-20.7%
129,514
-50.6%
0.00%
-100.0%
Q1 2018$2,142,000
+69.3%
262,386
+83.8%
0.00%
Q4 2017$1,265,000
-76.2%
142,721
-70.1%
0.00%
-100.0%
Q3 2017$5,319,000
+37.3%
477,867
+10.5%
0.00%
+100.0%
Q2 2017$3,873,000
-45.0%
432,305
-51.5%
0.00%0.0%
Q1 2017$7,036,000
-20.7%
891,628
-13.9%
0.00%0.0%
Q4 2016$8,878,000
+196.5%
1,035,950
+184.5%
0.00%0.0%
Q3 2016$2,994,000
-9.4%
364,190
-11.4%
0.00%0.0%
Q2 2016$3,306,000
+35.9%
411,265
+14.0%
0.00%0.0%
Q1 2016$2,432,000
+149.4%
360,817
+191.3%
0.00%
Q4 2015$975,000
-61.3%
123,883
-71.9%
0.00%
-100.0%
Q3 2015$2,522,000
+27.8%
440,102
+20.6%
0.00%0.0%
Q2 2015$1,974,000
-17.4%
364,881
-28.7%
0.00%0.0%
Q1 2015$2,389,000
+91.7%
511,775
+71.3%
0.00%
Q4 2014$1,246,000
-32.1%
298,696
-15.2%
0.00%
-100.0%
Q3 2014$1,836,000
+385.7%
352,240
+208.7%
0.00%
Q2 2014$378,000
+16.7%
114,106
+22.3%
0.00%
Q1 2014$324,000
-52.1%
93,278
-50.2%
0.00%
Q4 2013$677,000
+223.9%
187,126
+169.4%
0.00%
Q3 2013$209,000
-4.6%
69,472
+26.1%
0.00%
Q2 2013$219,00055,0730.00%
Other shareholders
NEOGENOMICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders